Cover Image
市場調查報告書

色素青光眼:全球臨床實驗趨勢

Pigment Glaucoma Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 339395
出版日期 內容資訊 英文 64 Pages
訂單完成後即時交付
價格
Back to Top
色素青光眼:全球臨床實驗趨勢 Pigment Glaucoma Global Clinical Trials Review, H2, 2015
出版日期: 2015年07月31日 內容資訊: 英文 64 Pages
簡介

本報告提供色素青光眼臨床實驗相關之最新趨勢分析,提供您各地區主要國家的臨床實驗數量,彙整臨床實驗的各階段進展,實驗對象採用狀況,有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 色素青光眼
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量

G7各國臨床實驗數量:眼科疾病治療藥臨床實驗上色素青光眼的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:眼科疾病治療藥臨床實驗上色素青光眼的比例

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

色素青光眼治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Novartis AG
    • Valeant Pharmaceuticals International, Inc.
    • Pfizer Inc.
    • Merck & Co., Inc.
    • 興和
    • Genovate Biotechnology Co., LTD.
    • Aurolab
    • Allergan Plc
    • Alcon, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Cardiff University
    • Johannes Gutenberg University Mainz
    • Medical University of Vienna
    • Yale University

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2798CTIDB

GlobalData's clinical trial report, "Pigment Glaucoma Global Clinical Trials Review, H2, 2015" provides an overview of Pigment Glaucoma clinical trials scenario. This report provides top line data relating to the clinical trials on Pigment Glaucoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Pigment Glaucoma
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Pigment Glaucoma to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Pigment Glaucoma to Ophthalmology Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Pigment Glaucoma
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Pigment Glaucoma Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Valeant Pharmaceuticals International, Inc.
      • Clinical Trial Overview of Valeant Pharmaceuticals International, Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Kowa Company, Ltd.
      • Clinical Trial Overview of Kowa Company, Ltd.
      • Genovate Biotechnology Co., LTD.
      • Clinical Trial Overview of Genovate Biotechnology Co., LTD.
      • Aurolab
      • Clinical Trial Overview of Aurolab
      • Allergan Plc
      • Clinical Trial Overview of Allergan Plc
      • Alcon, Inc.
      • Clinical Trial Overview of Alcon, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Cardiff University
      • Clinical Trial Overview of Cardiff University
      • Johannes Gutenberg University Mainz
      • Clinical Trial Overview of Johannes Gutenberg University Mainz
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Yale University
      • Clinical Trial Overview of Yale University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Pigment Glaucoma Therapeutics, Global, Clinical Trials by Region, 2015*
  • Pigment Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Pigment Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Proportion of Pigment Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Pigment Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Pigment Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Pigment Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Pigment Glaucoma Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Pigment Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Pigment Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Pigment Glaucoma Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Pigment Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa Company, Ltd., 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Genovate Biotechnology Co., LTD., 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Aurolab, 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan Plc, 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Alcon, Inc., 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiff University, 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Johannes Gutenberg University Mainz, 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2015*

List of Figures

  • Pigment Glaucoma Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Pigment Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Pigment Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Proportion of Pigment Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Pigment Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Pigment Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Pigment Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Pigment Glaucoma Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Pigment Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Pigment Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Pigment Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Pigment Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top